Mycophenolate Mofetil (Cellcept) Induced Pneumonitis: Case Report and Review of Literature

Iboro Udoete, MD.¹, Ngozika Orjioke MD., FCCP², Okelue Edwards Okobi MD.³ and M.Sc, Chinwendu Onuegbu, MD⁴

Abstract

Mycophenolate is used to treat several disease conditions. Several side effects have been reported in several reported cases; however, a few other side effects have been underreported, for example, post-transplant pneumonitis. This case demonstrates suspected mycophenolate-associated pneumonitis, which was masked by the concurrent immune-modulatory drugs that the patients were taking. The pneumonitis became evident after the withdrawal of the immune drugs. This seldomly reported pneumonitis and mycophenolate association calls for further vigilance and a high index of suspicion by physicians when pneumonitis develops in patients taking this valuable medication.

Keywords:

mycophenolate; pneumonitis; medication

Cite This Article

Udoete, I., Orjioke, N., Okobi, O. E., Onuegbu, C. (2021). Mycophenolate Mofetil (Cellcept) Induced Pneumonitis: Case Report and Review of Literature. International Journal of Scientific Advances (IJSCIA), Volume 2| Issue 5: Sep-Oct 2021, Pages 727-728 , URL: https://www.ijscia.com/wp-content/uploads/2021/09/Volume2-Issue5-Sep-Oct-No.157-727-728.pdf

Volume 2 | Issue 5: Sep-Oct 2021